For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Reference HPLC Analysis of NSAID Active Ingredient Nimesulide from a Topical Gel Formulation Using a Kinetex 2.6 µm Polar C18 Column
The active ingredient Nimesulide is a nonsteroidal anti-inflammatory drug (NSAID) which can be formulated into a gel or tablet form. Nimesulide presents a reversed phase analytical challenge because it’s found in a charged state under typical LC pH conditions. Because of the relative polarity of Nimesulide, several proposed reversed phase methods suggest the use of an ion-pairing agent. In this application, we investigated a non-ion-pairing reversed phase method that leveraged the unique dual selectivity of the Kinetex Polar C18 which combines a polar modified surface and the hydrophobic selectivity of a C18 stationary phase.

Reference HPLC Analysis of NSAID Active Ingredient Nimesulide from a Topical Gel Formulation Using a Kinetex 2.6 µm Polar C18 Column

The active ingredient Nimesulide is a nonsteroidal anti-inflammatory drug (NSAID) which can be formulated into a gel or tablet form. Nimesulide presents a reversed phase analytical challenge because it’s found in a charged state under typical LC pH conditions. Because of the relative polarity of Nimesulide, several proposed reversed phase methods suggest the use of an ion-pairing agent. In this application, we investigated a non-ion-pairing reversed phase method that leveraged the unique dual selectivity of the Kinetex Polar C18 which combines a polar modified surface and the hydrophobic selectivity of a C18 stationary phase.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Reversed Phase